- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03900702
Training to Enhance Cognition in Older Adults
April 1, 2019 updated by: Jeanne Townsend, PhD
Training Foundational Skills to Enhance Cognition in Older Adults
This is a planning project with a clinical trial pilot to prepare for a larger fully powered clinical trial.
Goals of this pilot project are: to identify and address any modifications of the games required for adaptation to diminished sensory abilities; to optimize training dosage and test timing of retention of effects; and to test and refine the battery of outcome assessments.
Primary outcome assessment are tests of attention distraction (subtest from a Useful Field of View Test).
This pilot will explore a number of secondary outcome measures including EEG and functional imaging biomarkers of change, measures of general cognitive improvement and measures of function including a driving simulator task.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a planning trial to optimize procedures for a larger clinical trial.
Participants will be randomized into one of two groups--an active group that has intervention training after initial visit and a wait control group that begins intervention after 12 weeks.
All participants will receive in-lab baseline testing including IQ (WASI-II), a medical/psychiatric history questionnaire, a depression screen (Geriatric Depression Scale Short Form) and a pre-training battery that includes selected tests from the NIH toolbox, the Repeatable Battery for Neuropsychological Status (RBANS), a Useful Field of View task (UFOV), a driving simulator task, a dual (motor-cognitive) task, an n-back task with and without distractors(with EEG) and 6 minutes of resting state EEG.
Participants will be trained to use the game system and play the game at the pre-training in-lab visit.
Participants will be provided with a PC with eye-tracker that has training game software installed.
Participants will play intervention training games at home for 8-12 weeks with in-lab assessments (the pre-training battery described above).
Participants will be asked to play the training games a minimum of 5 times per week for 30 minutes at a time.
Compliance will be monitored daily over a secure internet connection.
If a participant has played less than the required time in a given week, a research associate will contact the participant to inquire about potential problems and to encourage the participant to resume or increase training time.
The first group of 36 participants will receive post-training assessments at 8 weeks, 12 weeks and 6 months.
The second group of 36 participants will have an additional pre-training session with structural and functional imaging and will receive only pre- and post-training assessment.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92122
- Recruiting
- Research on Autism and Development Lab, UCSD
-
Contact:
- Anne M Engler
- Phone Number: 858-246-1931
- Email: amengler@ucsd.edu
-
Contact:
- Sarah Hacker
- Phone Number: 8582461931
- Email: shacker@ucsd.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 60-80 years old
- not demented
- living independently; and (4) fluent in English.
Exclusion Criteria:
- history of dementia, stroke, head injury involving loss of consciousness
- current psychiatric or neurological disorders other than depression/anxiety
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active Intervention
Gaze-driven games, played at home on PC with eye-tracker, to train resistance to attention distraction and speed of processing.
|
Training games are played on a PC with attached eye-tracker.
Games include embedded training principles to improve attentional control including resistance to distraction and inhibitory control.
|
No Intervention: Wait List Control
Wait list then cross over to active intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UFOV Attention Distraction
Time Frame: 12 weeks
|
Subtest from Useful Field of View Task
|
12 weeks
|
UFOV Speed of Processing
Time Frame: 12 weeks
|
Subtest from Useful Field of View Task
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Repeatable Battery for Neuropsychological Status (RBANS)
Time Frame: 12 weeks
|
Battery to assess general cognitive function
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jeanne Townsend, PhD, UCSD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2019
Primary Completion (Anticipated)
May 1, 2020
Study Completion (Anticipated)
September 1, 2020
Study Registration Dates
First Submitted
April 1, 2019
First Submitted That Met QC Criteria
April 1, 2019
First Posted (Actual)
April 3, 2019
Study Record Updates
Last Update Posted (Actual)
April 3, 2019
Last Update Submitted That Met QC Criteria
April 1, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- U01AG062371 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be available by request to the PI 1 year following completion of study.
Materials generated under the project will be disseminated in accordance with University/Participating institutional and NIH policies.
Depending on such policies, materials may be transferred to others under the terms of a material transfer agreement.
Access to databases and associated software tools generated under the project will be available for educational, research and non-profit purposes.
Such access will be provided using web-based applications, as appropriate.
IPD Sharing Time Frame
Data available 1 year following study completion and for 5 years subsequently.
IPD Sharing Access Criteria
Access for research or educational purposes, by application specifying use.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
Clinical Trials on Gaze-driven training games
-
University Hospital TuebingenGerman Research FoundationUnknownViolent Aggressive Behavior | Psychopathy | Emotional ProblemGermany
-
Stanford UniversityCompletedIntellectual Disability | Fragile X SyndromeUnited States
-
Duke UniversityCompleted
-
King's College LondonSouth London and Maudsley NHS Foundation TrustUnknownAnxiety | Adolescent BehaviorUnited Kingdom
-
University of LahoreCompletedChronic DizzinessPakistan
-
The Hong Kong Polytechnic UniversityCompletedNeuromuscular Diseases | Extraocular Muscle DisorderHong Kong
-
Michigan State UniversityJohns Hopkins University; Eunice Kennedy Shriver National Institute of Child... and other collaboratorsActive, not recruitingHIV Infections | HIV Exposed Uninfected | HUU Unexposed UninfectedMalawi, Uganda
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingChild Behavior | Adolescent BehaviorBrazil
-
University of Alabama, TuscaloosaRecruitingAffective Symptoms | EmpathyUnited States
-
Tel Aviv UniversityRecruitingPosttraumatic Stress DisorderIsrael